Els Van Nieuwenhuysen Selected Research

Els Van Nieuwenhuysen Research Topics

Disease

22	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 02/2015
18	Neoplasms (Cancer) 03/2024 - 12/2015
8	Carcinoma (Carcinomatosis) 08/2023 - 10/2014
5	Ovarian Epithelial Carcinoma 12/2023 - 12/2015
4	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2023 - 01/2020
3	Chromosomal Instability (Chromosome Stability) 04/2022 - 01/2016
2	Endometrial Neoplasms (Endometrial Cancer) 10/2023 - 12/2021
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Proteinuria 01/2022 - 01/2021
1	Granulosa Cell Tumor 03/2024
1	Genomic Instability 01/2023
1	Fatigue 01/2022
1	Epistaxis (Nosebleed) 01/2022
1	Ascites 01/2021
1	Thrombocytosis (Thrombocythemia) 01/2018
1	Febrile Neutropenia 02/2015
1	Thrombocytopenia (Thrombopenia) 02/2015
1	Neutropenia 02/2015
1	Anemia 02/2015
1	Dysgerminoma 07/2013
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 07/2013

Drug/Important Bio-Agent (IBA)

8	PlatinumIBA 12/2023 - 02/2015
5	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 12/2015
5	Carboplatin (JM8)FDA LinkGeneric 10/2023 - 12/2015
5	Bevacizumab (Avastin)FDA Link 08/2023 - 12/2020
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
3	Estrogen ReceptorsIBA 03/2024 - 06/2019
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2018
2	olaparibIBA 10/2023 - 01/2022
2	B7-H1 AntigenIBA 01/2023 - 12/2020
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
2	atezolizumabIBA 01/2023 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2018
2	Cell-Free Nucleic AcidsIBA 04/2022 - 05/2017
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2019
2	Vitamin D FDA LinkGeneric 01/2019 - 10/2016
1	ChromatinIBA 05/2024
1	abemaciclibIBA 03/2024
1	Letrozole (Femara)FDA LinkGeneric 03/2024
1	durvalumabIBA 10/2023
1	Thromboplastin (Tissue Factor)IBA 08/2023
1	tisotumab vedotinIBA 08/2023
1	pembrolizumabIBA 08/2023
1	Immunoconjugates (Immunoconjugate)IBA 08/2023
1	Tumor Biomarkers (Tumor Markers)IBA 05/2023
1	CyclinsIBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Nucleosomes (Nucleosome)IBA 04/2022
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	ParaffinIBA 12/2018
1	Interleukin-13IBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	CytokinesIBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Galectin 1 (LGALS1)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	InterleukinsIBA 01/2018
1	25-hydroxyvitamin DIBA 10/2016
1	hydroxide ionIBA 10/2016
1	taxaneIBA 02/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Histones (Histone)IBA 12/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2015
1	Hormones (Hormone)IBA 03/2015
1	GonadotropinsIBA 03/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2015
1	Cytochrome P-450 CYP3AIBA 02/2015
1	Taxoids (Taxanes)IBA 02/2015
1	pyrimidineIBA 10/2014
1	purineIBA 10/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2014
1	CarbonIBA 10/2014
1	CateninsIBA 07/2013

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 03/2024 - 02/2015
5	Therapeutics 03/2024 - 01/2016
4	Cytoreduction Surgical Procedures 12/2023 - 12/2015
3	Immunotherapy 10/2023 - 01/2021
2	Neoadjuvant Therapy 01/2021 - 11/2016
1	Activities of Daily Living (ADL) 01/2022
1	Hysterectomy 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Adjuvant Radiotherapy 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2020
1	Secondary Prevention 01/2020